Basic Information
LncRNA/CircRNA Name | LINC01561 |
Synonyms | NA |
Region | GRCh38_10:120597949-120600124 |
Ensemble | ENSG00000177234 |
Refseq | NR_103717 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | breast cancer |
ICD-0-3 | C50 |
Methods | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown |
Sample | breast cancer cell lines (MCF7, BT-20, ZR-75-1, and MX-1) |
Expression Pattern | up-regulated |
Function Description | qRT-PCR results identified that in BrCa cell lines, linc01561 and MMP11 were higher expressed while miR-145-5p was lower expressed compared with those in epithelial cell line. The linc01561 inhibition elevated miR-145-5p expression and then suppressed MMP11 expression. Moreover, linc01561 inhibition suppressed the BrCa cells proliferation and promoted the apoptosis, which was realized by up-regulating expression of miR-145-5p and down-regulating expression of MMP11. |
Pubmed ID | 29890225 |
Year | 2018 |
Title | Mixomics Analysis of Breast Cancer: Long Non-Coding RNA linc01561 Acts as ceRNA Involved in the Progression of Breast Cancer |
External Links
Links for LINC01561 | GenBank HGNC NONCODE |
Links for breast cancer | OMIM COSMIC |